Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to "CUX2/KDM5B/SOX17 Axis Affects the Occurrence and Development of Breast Cancer". | Endocrinology | 2022 | 36527259 | PubTator, text mining | PubMed |
| Primate gastrulation and early organogenesis at single-cell resolution. | Nature | 2022 | 36517595 | PubTator, text mining | PubMed |
| Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy. | Front Genet | 2022 | 36506323 | PubTator, text mining | PubMed |
| The CCN2 Polymorphism rs12526196 Is a Risk Factor for Ascending Thoracic Aortic Aneurysm. | Int J Mol Sci | 2022 | 36499730 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation. | Int J Mol Sci | 2022 | 36498923 | PubTator, text mining | PubMed |
| Drug Repurposing Applications to Overcome Male Predominance via Targeting G2/M Checkpoint in Human Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36497337 | PubTator, text mining | PubMed |
| FGFR Inhibitors in Cholangiocarcinoma-A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis? | Cells | 2022 | 36497187 | PubTator, text mining | PubMed |
| Stem-Cell-Derived β-Like Cells with a Functional PTPN2 Knockout Display Increased Immunogenicity. | Cells | 2022 | 36497105 | PubTator, text mining | PubMed |
| Sorting and Manipulation of Human PGC-LC Using PDPN and Hanging Drop Cultures. | Cells | 2022 | 36497094 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| Single-cell profiling of healthy human kidney reveals features of sex-based transcriptional programs and tissue-specific immunity. | Nat Commun | 2022 | 36496458 | PubTator, text mining | PubMed |
| Robust induction of primordial germ cells of white rhinoceros on the brink of extinction. | Sci Adv | 2022 | 36490332 | PubTator, text mining | PubMed |
| Profile of biological characterizations and clinical application of corneal stem/progenitor cells. | World J Stem Cells | 2022 | 36483848 | PubTator, text mining | PubMed |
| Somatic Variants in SVIL in Cerebral Aneurysms. | Neurol Genet | 2022 | 36475054 | PubTator, text mining | PubMed |
| Chemokine signaling synchronizes angioblast proliferation and differentiation during pharyngeal arch artery vasculogenesis. | Development | 2022 | 36468454 | PubTator, text mining | PubMed |
| Generation of Hepatocytes and Nonparenchymal Cell Codifferentiation System from Human-Induced Pluripotent Stem Cells. | Stem Cells Int | 2022 | 36467281 | PubTator, text mining | PubMed |
| Biomaterials and bioengineering to guide tissue morphogenesis in epithelial organoids. | Front Bioeng Biotechnol | 2022 | 36466337 | PubTator, text mining | PubMed |
| Comprehensive comparison of gene expression diversity among a variety of human stem cells. | NAR Genom Bioinform | 2022 | 36458020 | PubTator, text mining | PubMed |
| PGCLCs of human 45,XO reveal pathogenetic pathways of neurocognitive and psychosocial disorders. | Cell Biosci | 2022 | 36457060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=39